Functional suppression of TICRR significantly attenuated the proliferative and metastatic capacities of lung adenocarcinoma cells (Figure 1), highlighting TICRR as a promising therapeutic target in lung adenocarcinoma. Here, TICRR is linked to lung adenocarcinoma.